Sickle cell disease in pregnancy: Maternal complications in a medicaid-enrolled population

Maternal and Child Health Journal

Volumn 17, Issue 2, 2013, Pages 200-207

  Boulet, Sheree L ^a   Okoroh, Ekwutosi M ^b   Azonobi, Ijeoma ^b   Grant, Althea ^b   Craig Hooper, W ^b  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Pregnancy; Pregnancy complications; Sickle cell anemia; Sickle cell disease

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; FEMALE; HOSPITALIZATION; HUMAN; MEDICAID; NEGRO; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREVALENCE; RISK FACTOR; SICKLE CELL ANEMIA; SOCIOECONOMICS; STATISTICAL MODEL; STATISTICS; UNITED STATES;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ANEMIA, SICKLE CELL; CASE-CONTROL STUDIES; FEMALE; HOSPITALIZATION; HUMANS; INFANT, NEWBORN; LOGISTIC MODELS; MEDICAID; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; PREVALENCE; RISK FACTORS; SOCIOECONOMIC FACTORS; UNITED STATES; YOUNG ADULT;

MLCS; MLOWN;

EID: 84881244288     PISSN: 10927875     EISSN: 15736628     Source Type: Journal    
DOI: 10.1007/s10995-012-1216-3     Document Type: Article

References (24)

1. Brousseau, D. C., Panepinto, J. A., Nimmer, M., & Hoffmann, R. G. (2010). The number of people with sickle-cell disease in the United States: national and state estimates. American Journal of Hematology, 85(1), 77-78.
2. Hassell, K. L. (2010). Population estimates of sickle cell disease in the U.S. American Journal of Preventive Medicine, 38(4 Suppl), S512-S521.
3. Bonds, D. R. (2005). Three decades of innovation in the management of sickle cell disease: the road to understanding the sickle cell disease clinical phenotype. Blood Reviews, 19(2), 99-110.
4. Rogers, D. T., & Molokie, R. (2010). Sickle cell disease in pregnancy. Obstetrics and Gynecology Clinics of North America, 37(2), 223-237.
5. Howard, J., & Oteng-Ntim, E. (2012). The obstetric management of sickle cell disease. Best Practice and Research Clinical Obstetrics and Gynaecology, 26(1), 25-36.
6. Steinberg, M. H. (1999). Management of sickle cell disease. New England Journal of Medicine, 340(13), 1021-1030.
7. Rappaport, V. J., Velazquez, M., & Williams, K. (2004). Hemoglobinopathies in pregnancy. Obstetrics and Gynecology Clinics of North America, 31(2), 287-317. vi.
8. ACOG. (2007). Practice bulletin No. 78: Hemoglobinopathies in pregnancy. Obstetrics Gynecology, 109(1), 229-237.
9. Barfield, W. D., Barradas, D. T., Manning, S. E., Kotelchuck, M., & Shapiro-Mendoza, C. K. (2010). Sickle cell disease and pregnancy outcomes: women of African descent. American Journal of Preventive Medicine, 38(4 Suppl), S542-S549.
10. Villers, M. S., Jamison, M. G., De Castro, L. M., & James, A. H. (2008). Morbidity associated with sickle cell disease in pregnancy. American Journal of Obstetrics and Gynecology, 199(2), 125.
11. Truven health analytics. (2004-2010). Truven Health MarketScan® Multi-State Medicaid databases.
12. Kuklina, E. V., Whiteman, M. K., Hillis, S. D., Jamieson, D. J., Meikle, S. F., Posner, S. F., et al. (2008). An enhanced method for identifying obstetric deliveries: implications for estimating maternal morbidity. Maternal and Child Health Journal, 12(4), 469-477.
13. Sibai, B. H., Easterling, T. R., Stout, K., Whitty, J. E., Dombrowski, M. P., Colombo, D. F., et al. (2007). Pregnancy and existing disease. In S. G. Gabbe, J. R. Niebyl & J. L. Simpson (Eds.), Obstetrics normal and problem pregnancies (5th ed., pp. 861-1249). Philadelphia: Churchill Livingstone.
14. Sun, P. M., Wilburn, W., Raynor, B. D., & Jamieson, D. (2001). Sickle cell disease in pregnancy: twenty years of experience at Grady Memorial Hospital, Atlanta, Georgia. American Journal of Obstetrics and Gynecology, 184(6), 1127-1130.
15. Rogers, M. A., Levine, D. A., Blumberg, N., Flanders, S. A., Chopra, V., & Langa, K. M. (2012). Triggers of hospitalization for venous thromboembolism. Circulation, 125(17), 2092-2099.
16. James, A. H., Jamison, M. G., Brancazio, L. R., & Myers, E. R. (2006). Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. American Journal of Obstetrics and Gynecology, 194(5), 1311-1315.
17. Ataga, K. I., & Key, N. S. (2007). Hypercoagulability in sickle cell disease: New approaches to an old problem. Hematology American Society of Hematology Education Program, 91-96.
18. Stein, P. D., Beemath, A., Meyers, F. A., Skaf, E., & Olson, R. E. (2006). Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease. American Journal of Medicine, 119(10), 897-911.
19. Austin, H., Key, N. S., Benson, J. M., Lally, C., Dowling, N. F., Whitsett, C., et al. (2007). Sickle cell trait and the risk of venous thromboembolism among blacks. Blood, 110(3), 908-912.
20. Lopez Revuelta, K., & Ricard Andres, M. P. (2011). Kidney abnormalities in sickle cell disease. Nefrologia, 31(5), 591-601.
21. Yasmeen, S., Romano, P. S., Schembri, M. E., Keyzer, J. M., & Gilbert, W. M. (2006). Accuracy of obstetric diagnoses and procedures in hospital discharge data. American Journal of Obstetrics and Gynecology, 194(4), 992-1001.
22. Ku, L. (2009). Medical and dental care utilization and expenditures under medicaid and private health insurance. Medical care research and review, 66(4), 456-471.
23. Mvundura, M., Amendah, D., Kavanagh, P. L., Sprinz, P. G., & Grosse, S. D. (2009). Health care utilization and expenditures for privately and publicly insured children with sickle cell disease in the United States. Pediatric Blood & Cancer, 53(4), 642-646.
24. National heart, lung, and blood institute. Sickle cell disease awareness and education strategy development workshop report. U.S. Department of Health and Human Services, National Insititutes of Health. Available at: http://www.nhlbi.nih.gov/meetings/workshops/Sickle-Cell-Disease-Workshop.pdf. Accessed 18 Dec 2012.